Tevogen Bio Holdings Inc. Research And Development Expense

Quick Answer

Tevogen Bio Holdings Inc. reported Research And Development Expense of $11.11 million for the year ending 2025.

  • Tevogen Bio Holdings Inc. showed a decrease of -64.2% in Research And Development Expense from 2024 to 2025.
  • This data is from Tevogen Bio Holdings Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), Tevogen Bio Holdings Inc.'s Research And Development Expense has grown by 152.3%.
  • Historical annual values: Fiscal year 2025: $11.11 million | Fiscal year 2024: $31.03 million | Fiscal year 2023: $4.40 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: